Gain Therapeutics, Inc. (GANX)

NASDAQ: GANX · Real-Time Price · USD

1.850

-0.090 (-4.64%)

At close: Apr 2, 2026, 4:00 PM EDT

1.950

+0.100 (5.41%)

After-hours: Apr 2, 2026, 7:56 PM EDT

Gain Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	20.84	10.39	11.79	7.31	36.88
Short-Term Investments	-	-	5	12.83	-
Cash & Short-Term Investments	20.84	10.39	16.79	20.14	36.88
Cash Growth	100.64%	-38.16%	-16.61%	-45.40%	392.21%
Other Current Assets	1.4	1.22	0.98	0.95	0.84
Total Current Assets	22.24	11.6	17.78	21.09	37.72
Net Property, Plant & Equipment	0.41	0.32	0.59	0.8	1.01
Other Intangible Assets	0.1	0.13	0.19	0.21	0.2
Long-Term Investments	-	-	-	1.94	-
Other Long-Term Assets	0.07	0.06	0.05	0.05	0.05
Total Assets	22.82	12.12	18.61	24.1	38.99
Accounts Payable	0.83	0.95	1.32	1.63	0.56
Current Portion of Long-Term Debt	0.1	0.11	0.12	0.11	0.1
Current Portion of Leases	0.12	0.16	0.23	0.23	0.22
Unearned Revenue	-	0.25	1.12	0.06	0.27
Other Current Liabilities	2.31	2.44	2.16	2.11	1.4
Total Current Liabilities	3.35	3.91	4.95	4.13	2.55
Long-Term Debt	0.3	0.33	0.45	0.5	0.59
Long-Term Leases	0.21	0.05	0.23	0.44	0.7
Other Long-Term Liabilities	0.39	0.49	0.4	0.16	0.33
Total Long-Term Liabilities	0.9	0.87	1.08	1.09	1.61
Total Liabilities	4.25	4.78	6.03	5.22	4.17
Common Stock	0	0	0	0	0
Additional Paid-in Capital	119.14	88.78	73.11	57.36	55.83
Accumulated Other Comprehensive Income	0.78	-0.25	0.25	0.04	-0.09
Retained Earnings	-81.19	-60.78	-38.52	-20.93	-7.03
Shareholders' Equity	18.56	7.34	12.58	18.88	34.82
Total Liabilities & Equity	22.82	12.12	18.61	24.1	38.99
Total Debt	0.73	0.65	1.03	1.27	1.61
Net Cash (Debt)	20.11	9.73	15.77	18.86	35.27
Net Cash Growth	106.57%	-38.27%	-16.42%	-46.52%	466.03%
Net Cash Per Share	0.61	0.42	1.21	1.59	3.47
Book Value	18.56	7.34	12.58	18.88	34.82
Book Value Per Share	0.56	0.32	0.97	1.59	3.43
Tangible Book Value	18.46	7.21	12.38	18.67	34.61
Tangible Book Value Per Share	0.56	0.31	0.95	1.57	3.41

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q